(NU/1433-20) Skin Life Analytics: The Provision of Business Consultancy to Assist Commercialisation of University Research.
Estimated value
—
Awarded value
—
Suppliers
1
Lots
1
Published
30 Jul 2021
Description
The personal skin care market and cosmetics industry is becoming increasingly complex. The majority of consumers are looking for skincare products with validated clinical/scientific analysis and personalised products. Businesses need measurable evidence that their treatments are working to encourage continued product use as well as inform new product development and efficacy. Therefore, an experienced business executive is needed to join the team and lead the company formation. The initial brief of the executive will be to: (1) Produce a viable 5-year business plan; (2) Obtain university approval for the venture; (3) a. Act for the company in the spin-out legal process and address all company formation matters; b. Obtain founder academics’ and Newcastle University (including the Head of Company Creation) approval for appointment as CEO. c. Provide to the appropriate university all matters necessary all reporting requirements, including ERDF; (4) Secure (venture capital and other) funding Stage (4) will produce the funds by which the new start-up company can consider employing the executive going forward. It is expected, and the intent of the scheme, that the Executive will remain with the business following the end of the contract period. However, such appointment will be at the discretion of the board and appropriate university and will be subject to confirmation, typically at Stage 3 above
Scope
- Reference
- DN542818
- Commercial tool
- Standalone contract
- Main category
- services
- Contract locations
- North East England
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| o Ability to meet the required programme | P/F | quality | — |
| o Ability to meet the Job Description | P/F | quality | — |
| Ability to meet the Job Description | 60 | quality | — |
| o Equity | 15 | quality | — |
| o Acceptance of the equity approval process | P/F | quality | — |
| — | 25 | price | — |
Submission & procedure
- Procedure
- Restricted procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
—
Award date
—
Contract start
—
Contract end
—